Ablynx to Present at the Annual Jefferies 2013 Global Healthcare Conference

Ablynx to Present at the Annual Jefferies 2013 Global Healthcare Conference

ID: 264510

(firmenpresse) - GHENT, BELGIUM -- (Marketwired) -- 05/29/13 -- (EURONEXT BRUSSELS: ABLX) today announces it will present at the annual Jefferies 2013 Global Healthcare Conference in New York on Monday, 3rd June 2013 at 01:30 p.m. EST (07:30 p.m. CET).

The presentation, followed by a Q&A, will be hosted by Dr Edwin Moses, CEO and Chairman of Ablynx. The presentation will provide an update on the Company's late-stage proprietary Nanobody® programmes, the Company's growth and partnering strategy and the outlook for the near term future.

The presentation will be webcast live and can be accessed on the day via the Ablynx website at . A replay of the webcast will be available on the Company's website for 30 days following the presentation. To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.



Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has approximately 25 programmes in the pipeline and five Nanobodies at clinical development stage. Ablynx has on-going research collaborations and significant partnerships with major pharmaceutical companies including Boehringer Ingelheim, Merck Serono, Novartis and Merck & Co. The Company is headquartered in Ghent, Belgium. More information can be found on .

press release in pdf format:



Dr Edwin Moses
Chairman and CEO
t: +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
+32 (0)473 39 50 68
e:

Marieke Vermeersch
Associate Director Investor Relations
t: +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e:
Follow us on Twitter (at)AblynxABLX

Mary-Jane Elliott, Amber Bielecka, Claire Dickinson
t: +44 207 920 2330




e:

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Medical Business Systems Unveils Its Proprietary Connectivity Clearinghouse Edwards Lifesciences Comments on FDA Warning Letter
Bereitgestellt von Benutzer: Marketwired
Datum: 29.05.2013 - 16:39 Uhr
Sprache: Deutsch
News-ID 264510
Anzahl Zeichen: 0

contact information:
Town:

GHENT, BELGIUM



Kategorie:

Healthcare



Diese Pressemitteilung wurde bisher 329 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ablynx to Present at the Annual Jefferies 2013 Global Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

Ablynx (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Ablynx Announces Half-Year Results for 2013 ...

GHENT, BELGIUM -- (Marketwired) -- 08/21/13 -- (EURONEXT BRUSSELS: ABLX) today announced its results for the six-month period ending 30 June 2013, which have been prepared in accordance with the IAS 34 "Interim Financial Reporting" as adop ...

Ablynx Announces Warrant Exercise ...

GHENT, BELGIUM -- (Marketwired) -- 07/23/13 -- (EURONEXT BRUSSELS: ABLX) today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an additional 273,913 common shares have been issued by the ...

Alle Meldungen von Ablynx



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z